X |
Filing Date |
Trade Date |
Ticker |
Company Name | Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2026-03-15 | VANI | Vivani Medical, Inc. | Williams Gregg | Dir, 10% | P - Purchase | $1.07 | +1,575,231 | 36,156,383 | +5% | +$1,683,335 | ||||||
| M | 2026-03-05 | BLFS | Biolife Solutions Inc | Foster Karen A. | Chief Quality, Operations | S - Sale | $20.15 | -97,423 | 113,242 | -46% | -$1,962,998 | |||||
2026-03-06 | IRIX | Iridex Corp | Dizon Romeo R | CFO | P - Purchase | $1.26 | +1,110 | 121,000 | +1% | +$1,399 | ||||||
2026-03-04 | TMDX | Transmedics Group, Inc. | Lovell Stephanie | Dir | S - Sale | $149.62 | -1,193 | 2,866 | -29% | -$178,497 | ||||||
| D | 2026-03-04 | TMDX | Transmedics Group, Inc. | Weill David | Dir | S - Sale+OE | $146.82 | -3,571 | 12,134 | -23% | -$524,294 | |||||
2026-03-03 | BLFS | Biolife Solutions Inc | Werner Sean | CTO | S - Sale | $20.74 | -111 | 49,932 | 0% | -$2,302 | ||||||
2026-03-03 | BLFS | Biolife Solutions Inc | Foster Karen A. | Chief Quality, Operations | S - Sale | $20.74 | -418 | 210,665 | 0% | -$8,669 | ||||||
2026-03-03 | BLFS | Biolife Solutions Inc | Mathew Aby J. | EVP, Chief Scientific Officer | S - Sale | $20.74 | -529 | 392,937 | 0% | -$10,971 | ||||||
2026-03-03 | BLFS | Biolife Solutions Inc | Wichterman Troy | CFO | S - Sale | $20.74 | -588 | 220,649 | 0% | -$12,195 | ||||||
2026-03-03 | BLFS | Biolife Solutions Inc | Aebersold Sarah | CHRO | S - Sale | $20.74 | -219 | 93,360 | 0% | -$4,542 | ||||||
2026-03-03 | BLFS | Biolife Solutions Inc | Berard Todd | CMO | S - Sale | $20.74 | -353 | 165,940 | 0% | -$7,321 | ||||||
| D | 2026-03-03 | CBLL | Ceribell, Inc. | Foehr David | SVP, Finance, PAO | S - Sale+OE | $17.80 | -4,560 | 17,550 | -21% | -$81,168 | |||||
2026-03-03 | CBLL | Ceribell, Inc. | Robertson Rebecca B | Dir | S - Sale | $17.80 | -827 | 18,749 | -4% | -$14,721 | ||||||
| D | 2026-03-03 | CBLL | Ceribell, Inc. | Chao Xingjuan | Pres, CEO | S - Sale+OE | $17.45 | -39,000 | 1,080,252 | -3% | -$680,564 | |||||
| DM | 2026-03-02 | TMDX | Transmedics Group, Inc. | Hernandez Gerardo | CFO | S - Sale+OE | $146.81 | -7,611 | 14,689 | -34% | -$1,117,382 | |||||
2026-03-02 | TMDX | Transmedics Group, Inc. | Ranganath Anil P. | See remarks | S - Sale | $139.12 | -864 | 13,091 | -6% | -$120,200 | ||||||
2026-03-02 | TMDX | Transmedics Group, Inc. | Corcoran Nicholas | See Remarks | S - Sale | $139.12 | -2,966 | 29,831 | -9% | -$412,630 | ||||||
| D | 2026-03-02 | CBLL | Ceribell, Inc. | Woo Raymond | CTO | S - Sale+OE | $18.25 | -11,112 | 166,912 | -6% | -$202,839 | |||||
| D | 2026-02-19 | MDT | Medtronic Plc | Kiil Harry Skip | EVP, Pres Cardiovascular | S - Sale+OE | $97.71 | -52,524 | 32,768 | -62% | -$5,132,217 | |||||
| M | 2026-02-23 | CBLL | Ceribell, Inc. | Foehr David | SVP, Finance, PAO | S - Sale | $19.90 | -1,350 | 17,550 | -7% | -$26,865 | |||||
2026-02-23 | CBLL | Ceribell, Inc. | Manni Joseph S. | Chief Revenue Officer | S - Sale | $19.79 | -768 | 26,933 | -3% | -$15,199 | ||||||
2026-02-23 | CBLL | Ceribell, Inc. | Woo Raymond | CTO | S - Sale | $19.79 | -705 | 166,912 | 0% | -$13,952 | ||||||
2026-02-23 | CBLL | Ceribell, Inc. | Blumberg Scott | CFO | S - Sale | $19.79 | -808 | 118,334 | -1% | -$15,990 | ||||||
2026-02-23 | CBLL | Ceribell, Inc. | Chao Xingjuan | Pres, CEO | S - Sale | $19.79 | -2,084 | 1,094,252 | 0% | -$41,242 | ||||||
2026-02-19 | CBLL | Ceribell, Inc. | Parvizi Josef | Dir | S - Sale | $20.27 | -16,714 | 1,999,651 | -1% | -$338,793 | ||||||
2026-02-17 | OM | Outset Medical, Inc. | Brottem John L. | GC | S - Sale | $3.35 | -2,842 | 32,935 | -8% | -$9,521 | ||||||
2026-02-17 | OM | Outset Medical, Inc. | Trigg Leslie | Chair, CEO | S - Sale | $3.35 | -3,361 | 144,592 | -2% | -$11,259 | ||||||
2026-02-17 | OM | Outset Medical, Inc. | Nash Marc | EVP Operations R, D, Service | S - Sale | $3.35 | -1,817 | 39,988 | -4% | -$6,087 | ||||||
| M | 2026-02-17 | CBLL | Ceribell, Inc. | Parvizi Josef | Dir | S - Sale | $20.00 | -8,286 | 2,016,365 | 0% | -$165,720 | |||||
2026-02-18 | STEX | Streamex Corp. | Lekstrom Morgan Lee | Exec COB, 10% | P - Purchase | $2.50 | +20,000 | 122,500 | +20% | +$50,000 | ||||||
2026-02-13 | HYPR | Hyperfine, Inc. | Teisseyre Thomas | COO | S - Sale | $1.11 | -821 | 378,836 | 0% | -$913 | ||||||
2026-02-17 | IRIX | Iridex Corp | Dizon Romeo R | CFO | P - Purchase | $1.34 | +2,200 | 119,890 | +2% | +$2,942 | ||||||
2026-02-15 | VANI | Vivani Medical, Inc. | Williams Gregg | Dir, 10% | P - Purchase | $1.06 | +1,866,492 | 34,581,152 | +6% | +$1,983,333 | ||||||
| M | 2026-02-11 | NRX | Neuraxis, Inc | Hannasch Brian | 10% | P - Purchase | $4.79 | +80,000 | 1,211,522 | +7% | +$382,800 | |||||
2026-02-12 | IRIX | Iridex Corp | Dizon Romeo R | CFO | P - Purchase | $1.43 | +1,500 | 117,690 | +1% | +$2,145 | ||||||
2026-02-10 | IRIX | Iridex Corp | Dizon Romeo R | CFO | P - Purchase | $1.46 | +1,000 | 116,190 | +1% | +$1,460 | ||||||
| A | 2025-07-03 | CV | Capsovision, Inc | Tsai Chen Lung | Dir | P - Purchase | $4.17 | +20 | 20 | New | +$83 | |||||
| D | 2026-02-04 | CBLL | Ceribell, Inc. | Chao Xingjuan | Pres, CEO | S - Sale+OE | $20.16 | -39,000 | 1,096,336 | -3% | -$786,240 | |||||
| D | 2026-02-03 | CBLL | Ceribell, Inc. | Foehr David | SVP, Finance, PAO | S - Sale+OE | $20.00 | -5,556 | 18,900 | -23% | -$111,120 | |||||
2026-02-04 | STEX | Streamex Corp. | Giustra Frank | 10% | P - Purchase | $3.17 | +100,000 | 1,278,205 | +8% | +$317,000 | ||||||
| D | 2026-02-02 | CBLL | Ceribell, Inc. | Woo Raymond | CTO | S - Sale+OE | $20.55 | -11,112 | 167,617 | -6% | -$228,375 | |||||
2026-02-03 | IRIX | Iridex Corp | Dizon Romeo R | CFO | P - Purchase | $1.38 | +2,500 | 115,190 | +2% | +$3,450 | ||||||
2026-02-03 | STEX | Streamex Corp. | Lekstrom Morgan Lee | Dir, 10% | P - Purchase | $3.06 | +23,500 | 102,500 | +30% | +$71,910 | ||||||
| D | 2026-01-28 | MASI | Masimo Corp | Sampath Anand | EVP, Ops, Clinical Research | S - Sale+OE | $136.81 | -18,680 | 40,909 | -31% | -$2,555,570 | |||||
2026-01-29 | IRIX | Iridex Corp | Dizon Romeo R | CFO | P - Purchase | $1.44 | +1,101 | 112,690 | +1% | +$1,588 | ||||||
2026-01-29 | STEX | Streamex Corp. | Lekstrom Morgan Lee | Dir, 10% | P - Purchase | $3.70 | +2,500 | 79,000 | +3% | +$9,250 | ||||||
2026-01-28 | IRIX | Iridex Corp | Dizon Romeo R | CFO | P - Purchase | $1.46 | +1,300 | 111,589 | +1% | +$1,898 | ||||||
2026-01-27 | VANI | Vivani Medical, Inc. | Williams Gregg | Dir, 10% | P - Purchase | $1.48 | +1,351,351 | 32,714,660 | +4% | +$1,999,999 | ||||||
2026-01-23 | STEX | Streamex Corp. | Giustra Frank | 10% | P - Purchase | $3.00 | +1,000,000 | 1,178,205 | +561% | +$3,000,000 | ||||||
2026-01-27 | STEX | Streamex Corp. | Lekstrom Morgan Lee | Dir, 10% | P - Purchase | $3.12 | +5,500 | 76,500 | +8% | +$17,160 | ||||||
2026-01-27 | IRIX | Iridex Corp | Dizon Romeo R | CFO | P - Purchase | $1.48 | +3,385 | 110,289 | +3% | +$5,009 | ||||||
2026-01-26 | STEX | Streamex Corp. | Lekstrom Morgan Lee | Dir, 10% | P - Purchase | $3.30 | +23,000 | 71,000 | +48% | +$75,900 | ||||||
2026-01-23 | STEX | Streamex Corp. | Williams Mitchell Young | Chief Investment Officer | P - Purchase | $3.03 | +51,511 | 1,051,511 | +5% | +$155,852 | ||||||
2026-01-23 | STEX | Streamex Corp. | Lekstrom Morgan Lee | Dir | P - Purchase | $3.13 | +41,000 | 48,000 | +586% | +$128,486 | ||||||
2026-01-26 | IRIX | Iridex Corp | Dizon Romeo R | CFO | P - Purchase | $1.52 | +1,243 | 106,904 | +1% | +$1,889 | ||||||
| D | 2026-01-22 | QTIH | Qt Imaging Holdings, Inc. | Katz Avi S | COB | P - Purchase | $6.43 | +24,107 | 413,452 | +6% | +$155,008 | |||||
2026-01-23 | IRIX | Iridex Corp | Dizon Romeo R | CFO | P - Purchase | $1.48 | +5,221 | 105,661 | +5% | +$7,716 | ||||||
| M | 2026-01-20 | OM | Outset Medical, Inc. | Nash Marc | EVP Operations R, D, Service | S - Sale | $5.10 | -6,355 | 41,805 | -13% | -$32,400 | |||||
| M | 2026-01-20 | OM | Outset Medical, Inc. | Brottem John L. | GC | S - Sale | $5.11 | -10,494 | 35,777 | -23% | -$53,599 | |||||
| M | 2026-01-20 | OM | Outset Medical, Inc. | Trigg Leslie | Chair, CEO | S - Sale | $5.11 | -13,914 | 147,953 | -9% | -$71,091 | |||||
| M | 2026-01-20 | IRIX | Iridex Corp | Dizon Romeo R | CFO | P - Purchase | $1.50 | +4,259 | 100,440 | +4% | +$6,381 | |||||
2026-01-15 | CBLL | Ceribell, Inc. | Parvizi Josef | Dir | S - Sale | $22.94 | -25,000 | 2,024,651 | -1% | -$573,500 | ||||||
2026-01-15 | VANI | Vivani Medical, Inc. | Williams Gregg | Dir, 10% | P - Purchase | $1.14 | +1,737,765 | 31,363,309 | +6% | +$1,983,334 | ||||||
2026-01-16 | IRIX | Iridex Corp | Dizon Romeo R | CFO | P - Purchase | $1.43 | +3,496 | 96,181 | +4% | +$5,006 | ||||||
2026-01-07 | OM | Outset Medical, Inc. | Nash Marc | EVP Operations R, D, Service | S - Sale | $4.27 | -108 | 48,160 | 0% | -$461 | ||||||
2026-01-07 | OM | Outset Medical, Inc. | Brottem John L. | GC | S - Sale | $4.27 | -224 | 46,271 | 0% | -$956 | ||||||
2026-01-07 | OM | Outset Medical, Inc. | Trigg Leslie | Chair, CEO | S - Sale | $4.27 | -1,795 | 161,867 | -1% | -$7,665 | ||||||
2026-01-06 | BLFS | Biolife Solutions Inc | Wichterman Troy | CFO | S - Sale | $25.59 | -990 | 150,746 | -1% | -$25,334 | ||||||
2026-01-06 | BLFS | Biolife Solutions Inc | Foster Karen A. | Chief Quality, Operations | S - Sale | $25.59 | -335 | 191,984 | 0% | -$8,573 | ||||||
2026-01-06 | BLFS | Biolife Solutions Inc | Aebersold Sarah | CHRO | S - Sale | $25.59 | -241 | 75,765 | 0% | -$6,167 | ||||||
2026-01-06 | BLFS | Biolife Solutions Inc | Mathew Aby J. | EVP, Chief Scientific Officer | S - Sale | $25.59 | -405 | 349,350 | 0% | -$10,364 | ||||||
2026-01-06 | BLFS | Biolife Solutions Inc | Berard Todd | CMO | S - Sale | $25.59 | -344 | 132,564 | 0% | -$8,803 | ||||||
| D | 2026-01-05 | CBLL | Ceribell, Inc. | Foehr David | SVP, Finance, PAO | S - Sale+OE | $22.60 | -5,556 | 18,900 | -23% | -$125,566 | |||||
| D | 2026-01-05 | CBLL | Ceribell, Inc. | Chao Xingjuan | Pres, CEO | S - Sale+OE | $21.27 | -79,000 | 1,110,336 | -7% | -$1,680,048 | |||||
| D | 2026-01-02 | CBLL | Ceribell, Inc. | Woo Raymond | CTO | S - Sale+OE | $21.18 | -11,112 | 167,317 | -6% | -$235,382 | |||||
| D | 2026-01-02 | CBLL | Ceribell, Inc. | Robertson Rebecca B | Dir | S - Sale+OE | $21.89 | -2,500 | 19,576 | -11% | -$54,725 | |||||
| A | 2025-06-17 | CBLL | Ceribell, Inc. | Robertson Rebecca B | Dir | S - Sale | $17.63 | -7,445 | 21,230 | -26% | -$131,255 | |||||
2025-12-29 | VANI | Vivani Medical, Inc. | Mendelsohn Aaron | Dir | P - Purchase | $1.23 | +20,000 | 1,086,487 | +2% | +$24,600 | ||||||
2025-12-23 | NRXS | Neuraxis, Inc | Aharon Gil | Dir | P - Purchase | $3.52 | +286,138 | 286,138 | New | +$1,007,206 | ||||||
| D | 2025-12-22 | CBLL | Ceribell, Inc. | Blumberg Scott | CFO | S - Sale+OE | $21.00 | -36,000 | 118,842 | -23% | -$756,000 | |||||
2025-12-16 | IRIX | Iridex Corp | Moore William M | Dir | P - Purchase | $1.01 | +2,000 | 402,000 | +1% | +$2,020 | ||||||
2025-12-15 | CBLL | Ceribell, Inc. | Parvizi Josef | Dir | S - Sale | $21.49 | -25,000 | 2,049,651 | -1% | -$537,250 | ||||||
2025-12-09 | BLFS | Biolife Solutions Inc | Mathew Aby J. | EVP, Chief Scientific Officer | S - Sale | $25.13 | -631 | 349,755 | 0% | -$15,857 | ||||||
2025-12-09 | BLFS | Biolife Solutions Inc | Wichterman Troy | CFO | S - Sale | $25.13 | -1,033 | 151,736 | -1% | -$25,959 | ||||||
| M | 2025-12-09 | BLFS | Biolife Solutions Inc | Aebersold Sarah | CHRO | S - Sale | $24.63 | -946 | 76,006 | -1% | -$23,295 | |||||
2025-12-15 | BLFS | Biolife Solutions Inc | Duross Amy | Dir | S - Sale | $24.60 | -2,000 | 18,687 | -10% | -$49,200 | ||||||
2025-12-09 | BLFS | Biolife Solutions Inc | Berard Todd | CMO | S - Sale | $25.13 | -358 | 132,908 | 0% | -$8,997 | ||||||
2025-12-09 | BLFS | Biolife Solutions Inc | Foster Karen A. | Chief Quality, Operations | S - Sale | $25.13 | -519 | 192,319 | 0% | -$13,042 | ||||||
| D | 2025-12-16 | AXGN | Axogen, Inc. | Wendell Amy McBride | Dir | S - Sale+OE | $29.31 | -43,684 | 93,826 | -32% | -$1,280,465 | |||||
| D | 2025-12-16 | AXGN | Axogen, Inc. | Weiler Kathy Johnson | Dir | S - Sale+OE | $29.55 | -46,653 | 0 | -100% | -$1,378,476 | |||||
| D | 2025-12-15 | AXGN | Axogen, Inc. | Hartley Lindsey Marie | CFO | S - Sale+OE | $29.86 | -14,812 | 31,376 | -32% | -$442,294 | |||||
2025-12-15 | IRIX | Iridex Corp | Moore William M | Dir | P - Purchase | $0.00 | +20,000 | 400,000 | +5% | +$0 | ||||||
2025-12-15 | VANI | Vivani Medical, Inc. | Williams Gregg | Dir, 10% | P - Purchase | $1.14 | +1,737,765 | 29,625,544 | +6% | +$1,983,334 | ||||||
| M | 2025-12-11 | IRIX | Iridex Corp | Moore William M | Dir | P - Purchase | $0.00 | +30,000 | 380,000 | +9% | +$0 | |||||
2025-12-12 | IRIX | Iridex Corp | Dizon Romeo R | CFO | P - Purchase | $0.97 | +2,365 | 92,685 | +3% | +$2,296 | ||||||
2025-12-10 | AXGN | Axogen, Inc. | Dale Michael D | CEO | S - Sale | $30.00 | -25,000 | 63,537 | -28% | -$750,000 | ||||||
2025-12-11 | AXGN | Axogen, Inc. | Began Marc A | EVP, GC | S - Sale | $30.00 | -13,222 | 18,285 | -42% | -$396,660 | ||||||
| D | 2025-12-09 | CBLL | Ceribell, Inc. | Burke William W | Dir | S - Sale+OE | $22.02 | -32,728 | 17,391 | -65% | -$720,671 | |||||
2025-12-08 | CBLL | Ceribell, Inc. | Parvizi Josef | Dir | S - Sale | $20.26 | -25,000 | 2,074,651 | -1% | -$506,500 | ||||||
2025-12-09 | AXGN | Axogen, Inc. | Dale Michael D | CEO | S - Sale | $31.21 | -61,463 | 88,537 | -41% | -$1,918,137 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |